501 related articles for article (PubMed ID: 23773641)
1. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
Yang Y; Li Z; Wang L; Zhang F
Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
[TBL] [Abstract][Full Text] [Related]
2. Predicting Sjögren's syndrome in patients with recent-onset SLE.
Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
[TBL] [Abstract][Full Text] [Related]
3. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
[TBL] [Abstract][Full Text] [Related]
4. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
[TBL] [Abstract][Full Text] [Related]
5. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome.
Bartoloni E; Ludovini V; Alunno A; Pistola L; Bistoni O; Crinò L; Gerli R
Lupus; 2011 Aug; 20(9):928-35. PubMed ID: 21613330
[TBL] [Abstract][Full Text] [Related]
7. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset.
Baer AN; Maynard JW; Shaikh F; Magder LS; Petri M
J Rheumatol; 2010 Jun; 37(6):1143-9. PubMed ID: 20360189
[TBL] [Abstract][Full Text] [Related]
8. Predictors for future development of systemic lupus erythematosus in Korean Sjögren's syndrome patients.
Lee BW; Kwon EJ; Park Y; Lee JJ; Ju JH; Park SH; Kwok SK
Lupus; 2023 Oct; 32(12):1359-1368. PubMed ID: 37751679
[TBL] [Abstract][Full Text] [Related]
9. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
11. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
[TBL] [Abstract][Full Text] [Related]
12. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
13. Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.
Liu M; Wu X; Liu X; He J; Su Y; Guo J; Li Z
Hum Immunol; 2015 Nov; 76(11):808-11. PubMed ID: 26429306
[TBL] [Abstract][Full Text] [Related]
14. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients.
Choi JH; Park DJ; Kang JH; Yim YR; Lee KE; Lee JW; Wen L; Kim TJ; Park YW; Lee JK; Lee SS
Lupus; 2015 Oct; 24(12):1342-9. PubMed ID: 26085595
[TBL] [Abstract][Full Text] [Related]
16. Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome.
Sami F; Sami SA; Manadan AM; Arora S
Clin Rheumatol; 2024 Jan; 43(1):59-65. PubMed ID: 37980305
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome.
Matorras R; Ocerin I; Unamuno M; Nieto A; Peiró E; Burgos J; Expósito A
Lupus; 2007; 16(9):736-40. PubMed ID: 17728368
[TBL] [Abstract][Full Text] [Related]
18. Sjogren's syndrome in SLE: Part I. The frequency of the clinical and subclinical features of Sjogren's syndrome in patients with SLE.
Grennan DM; Ferguson M; Williamson J; Mavrikakis M; Dick WC; Buchanan WW
N Z Med J; 1977 Oct; 86(598):374-6. PubMed ID: 272546
[TBL] [Abstract][Full Text] [Related]
19. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and risk factors of neurological involvement in Sjögren's syndrome.
Ye W; Chen S; Huang X; Qin W; Zhang T; Zhu X; Zhu X; Lin C; Wang X
BMC Neurosci; 2018 Apr; 19(1):26. PubMed ID: 29703151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
